BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada

  April 16, 2025

   · 

  8 min read
• Press Releases

  XellSmart’s Allogeneic iPSC-derived Cell Therapies for Parkinson’s Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials

  April 16, 2025

   · 

  5 min read
• Press Releases

  SpineX Inc. Announces Significant Improvement in Urinary Bladder Function in Paralyzed Individuals with SCONE™ Therapy

  April 16, 2025

   · 

  2 min read
• Press Releases

  Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research

  April 16, 2025

   · 

  7 min read
• Press Releases

  Conference Call on Interim Report January-March 2025

  April 16, 2025

   · 

  1 min read
• 

  Earnings

  J&J Sets Tariff Tone as Q1 Earnings Begin To Roll In

  Analysts have had to throw out their assumptions for the biopharma industry’s recovery heading into the first quarter earnings period given the ongoing tariff drama.

  April 16, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 15, 2025

  April 16, 2025

   · 

  1 min read
• Press Releases

  Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

  April 16, 2025

   · 

  8 min read
• 

  Podcast

  Tariff Turmoil, FDA’s Future, Pfizer’s Obesity Setback and CEO Salaries Revealed

  Donald Trump takes biopharma on a tariff-themed rollercoaster ride; J&J kicks off the Q1 earnings season; experts express concern about the FDA’s future; Pfizer’s obesity setback could be Viking’s gain; and BioSpace reveals the highest paid pharma CEOs.

  April 16, 2025

   · 

  1 min read

   · 

  Heather McKenzie
• Press Releases

  IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

  April 16, 2025

   · 

  9 min read